27 Apr Coralan 7.5 mg Tablets (Ivabradine 7.5mg)
|
Company name & Address: |
Registration number |
Batch number(s) |
Expiry date |
Pack size |
First distributed |
Re-call Classification |
Recall date |
| Servier (Pty) Ltd 3rd Floor, Building J, Hertford Office Park, 90 Bekker Road, Vorna Valley, Midrand, 1686 |
A39/7.1.4/0411 |
719715
709702 705182 701085 705921 715957 697702 |
January 2026
April 2025 April 2025 March 2025 April 2025 November 2025 December 2024 |
56’s |
20 April 2024 22 March 2023 22 March 2023 02 September 2022 22 March 2023 27 July 2023 25 July 2023 |
Class II Type B |
22 July 2024 |
Reason for recalls
This recall is initiated as a result of a product packaging mistake lodged with Servier Laboratories. Some of the cartons (box) are incorrectly printed on the side panel, but the tablets inside the blisters are the correct tablets according to the carton.
Advice to HCPs/Distributors/Public
Please check if you have the above batches in stock and kindly return them to us. Please can you immediately return the affected boxes of Coralan 7,5 mg from Batch 719715, 709702, 705182, 701085, 705921, 715957, 697702 to your wholesaler for a full credit.
Proposed action taken and its urgency: A SAHPRA approved recall letter was distributed to all distribution points and the recall process was initiated.
Reporting side effects
Public and healthcare professionals are encouraged to report any side effects after using a health product or after immunisation by using the Med Safety App. Your report will contribute to our monitoring of these health products.